Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4887533 | 0.76 | MGLL (0.38) | GSK3AGSK3BMGLL | |
| SCHEMBL155452 | 0.72 | MGLL (0.35) | GSK3AGSK3BMGLL | |
| SCHEMBL2832318 | 0.66 | MGLL (0.41) | GSK3AGSK3BMGLL | |
| SCHEMBL22289873 | 0.66 | MGLL (0.41) | GSK3AGSK3BMGLL | |
| SCHEMBL3813596 | 0.66 | MGLL (0.32) | GSK3AGSK3BMGLL | |
| SCHEMBL9668855 | 0.65 | MGLL (0.32) | GSK3AGSK3BMGLL | |
| SCHEMBL43978 | 0.65 | MGLL (0.45) | GSK3AGSK3BMGLL | |
| SCHEMBL29017 | 0.65 | MGLL (0.45) | GSK3AGSK3BMGLL | |
| SCHEMBL4775219 | 0.63 | — | — | |
| SCHEMBL17924892 | 0.63 | MGLL (0.38) | GSK3AGSK3BMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8362276-B2 | Reacting a vinyl sulfone compound with imide compound in presence of catalyst | INKTEC CO., LTD. (KR) | 2013-01-29 | — | — | US | disclosed |
| US-20080262243-A1 | Beta-Sulfone Imides and Preparation Thereof | INKTEC CO., LTD. (KR) | 2008-10-23 | — | — | US | disclosed |
| WO-2006107175-A1 | BETA-SULFONE IMIDES AND PREPARATION THEREOF | INKTEC CO., LTD. (KR) | 2006-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262243-A1 | Beta-Sulfone Imides and Preparation Thereof | STS, CBS, SI | GSK3A 2281/4885GSK3B 1573/4885MGLL 4376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.